UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Section 13a-16 or 15d-16 of the
Securities Exchange Act of 1934

For the month of March 2023

Commission File Number: 001-39034

BELLUS HEALTH INC.
(Name of registrant)

275 Armand-Frappier Blvd.
Laval, Québec
H7V 4A7
Canada
 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F [   ] Form 40-F [ X ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1). ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____




SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: March 30, 2023   BELLUS Health Inc.
     
  By: /s/ Ramzi Benamar
  Name: Ramzi Benamar
  Title: Chief Financial Officer




Exhibit DESCRIPTION
   
99.1 Notice of the Meeting
99.2 Management Information Circular
99.3 Form of Proxy
99.4 Notice of Availability



BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more BELLUS Health Charts.
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more BELLUS Health Charts.